AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2017
May 9, 2017
34395_dirs_2017-05-09_fe50d502-5e98-41aa-8ee3-5bc4d663388d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-05-05
Reporting Person: Skaff Habib (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-05 | Common Stock | X | 3143 | $2.6 | Acquired | 19542 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-05 | Warrant (Right to Buy) | $2.6 | X | 3143 | Disposed | 2017-05-10 | Common Stock (3143) | Direct |
Footnotes
F1: On May 5, 2017, the Reporting Person exercised a warrant to purchase 3,143 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017.